JSA assists IndiaRF in acquisition of majority stake in Ivy Health

The acquisition has been made for ₹525 crore.
India Resurgence Fund
India Resurgence Fund

India Resurgence Fund (IndiaRF) has acquired a majority stake in Ivy Health and Life Sciences Private Limited for ₹525 crore.

JSA assisted IndiaRF in this acquisition deal.

The transaction team consisted of Sidharrth Shankar (Lead Partner), Prakriti Jaiswal (Partner), Dhruv Malhotra (Principal Associate) and Shivek Sharma (Senior Associate), with assistance from:

Due Diligence team: Shraddha Krishnan Dash (Partner) , Arjun Krishnamoorthy (Principal Associate), Abhilash Raghav (Associate), Jatin Oberoi (Associate), Jeevesh Jain (Associate) and Kartikey Gupta (Associate).

Real Estate team: Bharat Bhushan Sharma (Partner) and Mohit Aggarwal (Senior Associate).

Competition Law team: Vaibhav Choukse (Partner), Ela Bali (Partner) and Faiz Siddiqui (Associate).

Banking and Finance team: Megha Saraf (Partner) and Harshil Shubham (Associate)

Ivy Health operates a chain of NABH-certified multi-speciality hospitals in several cities of Punjab namely at Mohali, Amritsar, Khanna, Hoshiarpur and Nawanshahr.

IndiaRF is a leading India-focused investment fund, backed by Piramal Enterprises Limited and Bain Capital Credit. The deal marks their maiden investment in the healthcare sector and the first of its kind in a regional hospital chain.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Bar and Bench - Indian Legal news